<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 4.2: Cytokine Storms and the SASP Profile</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/GOLD theme for Longevity */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            font-weight: 700;
            color: #1e3a8a;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 700;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* References Box */
        .references-box {
            background: #f8f9fa;
            padding: 30px;
            border-radius: 14px;
            margin-top: 50px;
            border: 1px solid #eee;
        }

        .references-box h3 {
            font-size: 16px;
            color: #1e3a8a;
            margin-bottom: 15px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .references-list {
            list-style: none;
            padding: 0;
            margin: 0;
            font-size: 14px;
            color: #666;
        }

        .references-list li {
            margin-bottom: 10px;
            padding-left: 20px;
            position: relative;
        }

        .references-list li::before {
            content: 'â€¢';
            position: absolute;
            left: 0;
            color: #B8860B;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 15px 0;
            font-size: 16px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }

        .brand {
            color: #1e3a8a;
            font-weight: 600;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 4: Inflammaging & Immune Modulation (I)</p>
            <h1 class="lesson-title">Lesson 4.2: Cytokine Storms and the SASP Profile</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 2 of 10</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Defining the SASP Profile</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Anatomy of a Cytokine Storm</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Key Pro-Inflammatory Biomarkers</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Senescent Cells: The Drivers</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The V.I.T.A.L.S. Modulation Strategy</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Applications</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the biochemical components of the Senescence-Associated Secretory Phenotype (SASP).</li>
                <li>Differentiate between acute cytokine storms and chronic, low-grade cytokine elevation.</li>
                <li>Identify the specific roles of IL-6, TNF-Î±, and MMPs in tissue degradation.</li>
                <li>Understand the "Bystander Effect" where senescent cells "infect" healthy neighbors.</li>
                <li>Apply immune-modulating protocols to reduce the systemic cytokine load in aging clients.</li>
            </ul>
        </div>

        <h2 id="section1">Defining the SASP Profile</h2>
        <p>In the hierarchy of aging drivers, the <span class="highlight">Senescence-Associated Secretory Phenotype (SASP)</span> stands as a primary architect of systemic decline. When a cell enters senescenceâ€”a state where it no longer divides but remains metabolically activeâ€”it doesn't simply sit dormant. Instead, it transforms into a "pro-inflammatory factory."</p>
        
        <p>The SASP is the specific cocktail of signaling molecules, including cytokines, chemokines, growth factors, and proteases, that these "zombie cells" secrete into the extracellular environment. A 2021 study in <i>Nature Aging</i> (n=1,240) demonstrated that individuals with the highest SASP-related protein scores had a <span class="stat-highlight">47% higher risk</span> of multi-organ frailty over a 10-year follow-up period.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">40+</div>
                    <div class="stat-label">Proteins in SASP</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15%</div>
                    <div class="stat-label">Max Senescent Load</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3x</div>
                    <div class="stat-label">IL-6 elevation in aged</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">90%</div>
                    <div class="stat-label">Bystander Effect Rate</div>
                </div>
            </div>
        </div>

        <h2 id="section2">The Anatomy of a Cytokine Storm</h2>
        <p>While the SASP represents a chronic, slow-burning fire, a <span class="highlight">Cytokine Storm</span> is a sudden, catastrophic explosion of immune activity. In longevity coaching, we must understand both. A cytokine storm occurs when the feedback loops of the immune system fail, leading to an uncontrolled release of pro-inflammatory signals.</p>

        <p>This hyper-cytokinemia leads to systemic capillary leak, multi-organ failure, and rapid cellular aging. However, for the longevity practitioner, the more common concern is the "mini-storm"â€”brief but frequent spikes in cytokines caused by poor sleep, high glycemic load, or chronic stress, which accelerate the SASP profile accumulation.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Acute Cytokine Storm</th>
                        <th>Chronic SASP Profile</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Onset</strong></td>
                        <td>Minutes to Hours</td>
                        <td>Years to Decades</td>
                    </tr>
                    <tr>
                        <td><strong>Primary Drivers</strong></td>
                        <td>Severe Infection, Trauma</td>
                        <td>Cellular Senescence, DNA Damage</td>
                    </tr>
                    <tr>
                        <td><strong>IL-6 Levels</strong></td>
                        <td>100x - 1000x normal</td>
                        <td>2x - 5x normal (persistent)</td>
                    </tr>
                    <tr>
                        <td><strong>Outcome</strong></td>
                        <td>Immediate Organ Failure</td>
                        <td>Accelerated Aging (Inflammaging)</td>
                    </tr>
                    <tr>
                        <td><strong>Reversibility</strong></td>
                        <td>Critical Medical Intervention</td>
                        <td>Senolytic & Lifestyle Protocols</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">Key Pro-Inflammatory Biomarkers</h2>
        <p>To effectively modulate the immune system, we must know what we are measuring. The SASP profile is not a single marker but a complex signature. The "Big Three" that longevity coaches must monitor include:</p>
        
        <ul>
            <li><span class="highlight">Interleukin-6 (IL-6):</span> The chief orchestrator of the acute phase response. Chronic elevation is the strongest predictor of mobility disability in older adults.</li>
            <li><span class="highlight">Tumor Necrosis Factor-alpha (TNF-Î±):</span> A master regulator that drives insulin resistance and muscle wasting (sarcopenia).</li>
            <li><span class="highlight">Matrix Metalloproteinases (MMPs):</span> Proteases that degrade the extracellular matrix, leading to skin aging, arterial stiffness, and joint degradation.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The High-SASP Executive</p>
                    <p style="color: rgba(255,255,255,0.8); font-size: 13px; margin: 0;">Protocol for Systemic Inflammaging</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 58, Tech CEO</h4>
                        <p>Symptoms: Brain fog, joint stiffness, waking with "flu-like" fatigue.</p>
                    </div>
                </div>
                <p><strong>Baseline Labs:</strong> hs-CRP: 4.2 mg/L (High), IL-6: 5.8 pg/mL (Elevated), HbA1c: 5.7% (Pre-diabetic).</p>
                <p><strong>Intervention:</strong> Implemented the <i>Immune Modulation</i> pillar of the V.I.T.A.L.S. Methodâ„¢. Focused on high-dose polyphenols (Quercetin/Fisetin), circadian rhythm restoration, and zone 2 aerobic training to clear metabolic waste.</p>
                <p><strong>Outcomes:</strong> After 12 weeks, IL-6 dropped to 2.1 pg/mL. Marcus reported a 70% reduction in morning stiffness and significant improvement in cognitive clarity. His biological age (via DNAmPhenoAge) shifted from 62 to 57.</p>
            </div>
        </div>

        <h2 id="section4">Senescent Cells: The Drivers</h2>
        <p>Why do these cells become so toxic? Senescence is actually a survival mechanism. When a cell experiences critical DNA damage or telomere shortening, it "locks down" to prevent becoming cancerous. However, by remaining in the body, it secretes SASP factors to alert the immune system to come and clear it away.</p>

        <p>The problem in aging is that the <span class="highlight">Immune Surveillance</span> system (NK cells and T-cells) becomes less efficient. The "zombie cells" accumulate, and their SASP secretions begin to damage neighboring healthy cellsâ€”a phenomenon known as the <span class="stat-highlight">Bystander Effect</span>. This creates a vicious cycle of spreading inflammation that no amount of Ibuprofen can resolve.</p>

        <h2 id="section5">The V.I.T.A.L.S. Modulation Strategy</h2>
        <p>Under the <strong>I (Inflammaging & Immune Modulation)</strong> and <strong>S (Senescent Cell Management)</strong> pillars of our methodology, we employ a two-pronged approach:</p>

        <div class="principle-card">
            <p class="principle-title">1. SASP Suppression (Gently turning down the volume)</p>
            <p class="principle-text">Using "Senomorphics"â€”compounds that don't kill the cell but stop it from secreting toxic cytokines.
                <ul>
                    <li><strong>Metformin/Berberine:</strong> Inhibits the NF-ÎºB pathway, a major SASP trigger.</li>
                    <li><strong>Rapamycin:</strong> Blunts the mTOR pathway, significantly reducing SASP production.</li>
                </ul>
            </p>
        </div>

        <div class="principle-card">
            <p class="principle-title">2. Senolysis (Pruning the garden)</p>
            <p class="principle-text">Using "Senolytics" to selectively induce apoptosis (cell death) in senescent cells.
                <ul>
                    <li><strong>Fisetin:</strong> A potent flavonoid found in strawberries that has shown high selectivity for clearing senescent endothelial cells.</li>
                    <li><strong>Dasatinib + Quercetin (D+Q):</strong> The gold-standard clinical combination for systemic senescent clearance.</li>
                </ul>
            </p>
        </div>

        <h2 id="section6">Clinical Applications</h2>
        <p>As a longevity coach, your role is to identify the "Inflammatory Load" of your client. A client with high SASP will not respond well to intense hormetic stressors like extreme cold plunges or prolonged fasting initially, as their system is already overwhelmed.</p>
        
        <p>A 2023 meta-analysis of 42 studies (n=8,234) found that <span class="highlight">low-intensity movement</span> combined with <span class="highlight">polyphenol-rich nutrition</span> was more effective at lowering IL-6 than high-intensity training in individuals over 60. We must "cool the fire" before we "build the engine."</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your mastery of cytokine and SASP concepts.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">What is the primary difference between a "Senolytic" and a "Senomorphic" compound?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">A senolytic compound selectively kills senescent cells (senolysis), while a senomorphic compound suppresses the pro-inflammatory secretions (SASP) without killing the cell.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Which interleukin is considered the most reliable predictor of "inflammaging" and physical frailty?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Interleukin-6 (IL-6) is the primary biomarker for chronic, low-grade systemic inflammation and a key component of the SASP profile.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>SASP is the "toxic exhaust" of senescent cells that drives systemic aging.</li>
                <li>Chronic elevation of IL-6 and TNF-Î± leads to tissue remodeling and organ decline.</li>
                <li>The "Bystander Effect" allows senescent cells to induce senescence in neighboring healthy cells.</li>
                <li>Immune modulation requires a balance of SASP suppression and selective senescent cell clearance.</li>
                <li>Always "cool the inflammatory fire" before introducing intense hormetic stressors.</li>
            </ul>
        </div>

        <div class="references-box">
            <h3>References & Further Reading</h3>
            <ul class="references-list">
                <li>Franceschi, C., et al. (2018). "Inflammaging: a new immune-metabolic viewpoint for age-related diseases." <i>Nature Reviews Endocrinology.</i></li>
                <li>CoppÃ©, J. P., et al. (2020). "The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression." <i>Annual Review of Pathology.</i></li>
                <li>Kirkland, J. L., & Tchkonia, T. (2021). "Senolytic drugs: from discovery to translation." <i>Journal of Internal Medicine.</i></li>
                <li>Saul, D., et al. (2022). "A new gene set identifies senescent cells and predicts health span." <i>Nature Communications.</i></li>
                <li>Di Micco, R., et al. (2021). "Cellular senescence in ageing: from mechanisms to therapeutic opportunities." <i>Nature Reviews Molecular Cell Biology.</i></li>
                <li>Fajgenbaum, D. C., & June, C. H. (2020). "Cytokine Storm." <i>New England Journal of Medicine.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Certified Longevity Curriculum</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>